The Share

The Diamyd Medical share is traded on Nasdaq First North (ticker : DMYD B). ISIN code: SE0005162880.

About Nasdaq First North

Nasdaq First North is an alternative marketplace operated by an exchange within the Nasdaq Group. Companies on Nasdaq First North are not subject to the same rules as companies on the regulated main market. Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a company on Nasdaq First North may therefore be higher than investing in a company on the main market. All companies with shares traded on Nasdaq First North have a Certified Adviser who monitors that the rules are followed. The Exchange approves the application for admission to trading.

Certified Adviser at Nasdaq First North

FNCA Sweden AB, Humlegårdsgatan 5, Box 5807, SE-102 48 Stockholm. Tel: 08-528 00 399, E-mail: info@fnca.se.
  Quarterly Report 2, March 27, 2019

Dear Shareholders and readers

Our European phase IIb trial DIAGNODE-2, where the diabetes vaccine Diamyd® is administered three times in a superficial lymph node is close to being fully recruited. Currently, 93 out of 106 patients have been randomized and in the beginning of March we were able to give the green light to the clinic in Rotterdam in the Netherlands to start recruiting. This together with high patient retention rate ensures that we keep our timelines and will close the trial for recruitment during the spring....

We are seeing increased international visibility highlighting the work we are doing.
Ulf Hannelius, President and CEO

Calendar

  
May 29, 2019
Biotech Investorkonference Q2 2019
Copenhagen, Denmark
June 7 − June 11, 2019
American Diabetes Association’s 79th Scientific Sessions
June 26, 2019
Quarterly Report III
Quarterly Report 3 2018/2019
October 2, 2019
Year-End Report
Year-End Report 2018/2019
 

We are dedicated to finding a cure for autoimmune diabetes through pharmaceutical development and investments in medical and stem cell technologies

 

Ten largest shareholders as of March 29, 2019

ShareholderA SharesB SharesCapital %Votes %
Essen-Möller, Anders 2 556 223 7 333 040 14.30 35.69
Avanza Pension 8 485 931 12.27 9.21
Lindkvist, Bertil 6 160 000 8.91 6.68
Nordnet Pension 2 698 435 3.90 2.93
Swedbank Försäkring 1 083 758 1.57 1.18
Hansen, Patrik 1 030 000 1.49 1.12
Konstruktions o Försäljningsaktiebolag 740 000 1.07 0.80
Arandi Development AB 505 000 0.73 0.55
Relbo AB 475 550 0.69 0.52
Schelé, Sven 460 000 0.67 0.50
Remaining shareholders 37 641 859 54.4 40.80
Total 2 556 223 66 613 573 100.0 100.0